stockrowVeeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025.
- Revenue
- +17.6%
- EPS
- +36.6%
- Free cash flow
- −0.62%
Quarter to July 2026, against a year earlier
Follow VEEV
Alert me
Veeva Systems Inc. (VEEV) Return on equity
Veeva Systems Inc.'s return on equity over the twelve months to 31 July 2026 was 14.4%, up 0.5 percentage points from fiscal 2026 (13.9%). Over the past ten years it has ranged from 11.7% (fiscal 2015) to 21.4% (fiscal 2019); the current reading is higher than 50% of that period. That is above the Health Information Services industry median of −3.15% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | 13.9% | 0.30 |
| FY2025 | 13.6% | 1.05 |
| FY2024 | 12.6% | (2.14) |
| FY2023 | 14.7% | (1.79) |
| FY2022 | 16.5% | (2.82) |
| FY2021 | 19.3% | (1.41) |
| FY2020 | 20.7% | (0.70) |
| FY2019 | 21.4% | 2.04 |
| FY2018 | 19.4% | 6.00 |
| FY2017 | 13.4% | 1.47 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| HNGE Hinge Health Inc. compare | 41.4% |
| HTFL Heartflow, Inc. compare | 38.5% |
| BTSG BrightSpring Health Services, Inc. compare | 20.5% |
| VEEV Veeva Systems Inc. | 14.4% |
| DOCS Doximity, Inc. compare | 13.8% |
| HQY HealthEquity, Inc. compare | 11.4% |
| PRVA Privia Health Group, Inc. compare | 4.25% |
| WAY Waystar Holding Corp. compare | 3.72% |
| TEM Tempus AI, Inc. compare | −37.6% |
| Health Information Services industry median | −3.15% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement